9004-10-8 | Insulin

Chemical type

• Peptide hormone
• Produced by beta cells in the pancreas

Key properties

• Regulates blood glucose levels by facilitating cellular uptake of glucose
• Insufficient production or inadequate regulation leads to hyperglycemia in DMT2
• Influences long-term complications of diabetes if not properly managed

• Therapeutic agent in DMT2 management (e.g., via injections or pumps for patients with poor natural regulation)
• Key factor in self-care and medical treatment for maintaining glucose control
• Referenced in diabetes etiology, but not directly measured in the study's CGM data

Classification by use

• Hormones in metabolic regulation
• Therapeutic agents for endocrine disorders

A trustworthy factory and manufacturer

Demei Chemical Technology Co., Ltd. is a modern high-tech enterprise integrating R&D, production, and sales. The company's founder, Dr. Arron, born in April 1975, graduated from the School of Mechanical Engineering at Yanshan University and has been engaged in research in the fields of mechanical engineering and chemical synthesis for many years. The company's products focus on the chemical industry, primarily dealing in chemical raw materials and chemical production machinery and equipment. With its strong technical capabilities, advanced production equipment, and strict quality management system, the company has earned the trust of customers worldwide.

1. Use of the Geometric Pattern Transformation to detect diabetes mellitus type 2 from blood Insulin signals, Biomedical Engineering Advances, Volume 11, June 2026, 100205